RxSight Inc (NASDAQ: RXST) kicked off on Tuesday, down -9.75% from the previous trading day, before settling in for the closing price of $16.61. Over the past 52 weeks, RXST has traded in a range of $14.37-$66.54.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 172.93% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded 14.49%. With a float of $38.38 million, this company’s outstanding shares have now reached $40.43 million.
In an organization with 498 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 65.95%, operating margin of -24.57%, and the pretax margin is -18.27%.
RxSight Inc (RXST) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Medical Devices Industry. The insider ownership of RxSight Inc is 5.20%, while institutional ownership is 87.20%. The most recent insider transaction that took place on Mar 12 ’25, was worth 180,002. In this transaction Director of this company sold 7,000 shares at a rate of $25.71, taking the stock ownership to the 24,793 shares. Before that another transaction happened on Mar 12 ’25, when Company’s Director proposed sale 7,000 for $25.71, making the entire transaction worth $180,002.
RxSight Inc (RXST) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 14.49% per share during the next fiscal year.
RxSight Inc (NASDAQ: RXST) Trading Performance Indicators
Take a look at RxSight Inc’s (RXST) current performance indicators. Last quarter, stock had a quick ratio of 10.50. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.34.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.71, a number that is poised to hit -0.21 in the next quarter and is forecasted to reach -0.41 in one year’s time.
Technical Analysis of RxSight Inc (RXST)
Let’s dig in a bit further. During the last 5-days, its volume was 2.29 million. That was better than the volume of 0.73 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 12.41%. Additionally, its Average True Range was 2.01.
During the past 100 days, RxSight Inc’s (RXST) raw stochastic average was set at 1.85%, which indicates a significant decrease from 4.86% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 203.31% in the past 14 days, which was higher than the 89.10% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $27.50, while its 200-day Moving Average is $42.04. However, in the short run, RxSight Inc’s stock first resistance to watch stands at $16.77. Second resistance stands at $18.55. The third major resistance level sits at $19.59. If the price goes on to break the first support level at $13.96, it is likely to go to the next support level at $12.92. The third support level lies at $11.14 if the price breaches the second support level.
RxSight Inc (NASDAQ: RXST) Key Stats
The company with the Market Capitalisation of 606.95 million has total of 40,491K Shares Outstanding. Its annual sales at the moment are 139,930 K in contrast with the sum of -27,460 K annual income. Company’s last quarter sales were recorded 40,210 K and last quarter income was -5,940 K.
